Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s40256-016-0198-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy: Quo Vadis?
J Am Coll Cardiol
August 2022
Heart Failure Clinics, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Response to: Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogeneic Hematopoietic Cell Transplantation.
Intern Med
March 2023
Department of Neurology, Hematology, Diabetology, Endocrinology, and Metabolism (3rd Department of Internal Medicine), Faculty of Medicine, Yamagata University, Japan.
Guideline-based audit of the hospital management of heart failure with reduced ejection fraction.
Intern Med J
September 2023
Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Background: Heart failure is a major burden in Australia in terms of morbidity, mortality and healthcare expenditure. Multiple evidence-based therapies are recommended for heart failure with reduced ejection fraction (HFrEF), but data on physician adherence to therapy guidelines are limited.
Aim: To compare use of HFrEF therapies against current evidence-based guidelines in an Australian hospital inpatient population.
Ivabradine for Postoperative JET: Clear for Take-Off?
JACC Clin Electrophysiol
August 2021
Department of Physiology and Membrane Biology and Department of Pharmacology, School of Medicine, University of California-Davis, Davis, California, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!